Validation of apixaban anti-factor Xa assay and impact of body weight

Direct oral anticoagulants (DOACs) are widely used as therapies for venous thromboembolism and other cardiovascular diseases. However, routine coagulation monitoring is not required, but may be clinically indicated in high risk populations including obese patients.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Full Length Article Source Type: research